Total Payments
$706.35
2024 Payments
$124.41
Companies
8
Transactions
22
Medicare Patients
4,555
Medicare Billing
$635,780
Payment Breakdown by Category
Food & Beverage$706.35 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $706.35 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $305.72 | 9 | $0 (2024) |
| Beckman Coulter, Inc. | $113.81 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $90.96 | 4 | $0 (2024) |
| ABBVIE INC. | $64.98 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $54.98 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $45.42 | 1 | $0 (2018) |
| Philips Electronics North America Corporation | $15.75 | 1 | $0 (2022) |
| Mylan Specialty L.P. | $14.73 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.41 | 6 | ABBVIE INC. ($43.49) |
| 2023 | $139.44 | 6 | PFIZER INC. ($88.63) |
| 2022 | $119.42 | 6 | E.R. Squibb & Sons, L.L.C. ($54.98) |
| 2021 | $113.81 | 1 | Beckman Coulter, Inc. ($113.81) |
| 2019 | $163.85 | 2 | PFIZER INC. ($163.85) |
| 2018 | $45.42 | 1 | AstraZeneca Pharmaceuticals LP ($45.42) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/21/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/26/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/16/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/14/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, ZAVZPRET | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/01/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/21/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/30/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/17/2022 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Medical Device | ||||||
| 07/19/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/07/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| Category: Cardiovascular | ||||||
| 06/30/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/07/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $40.20 | General |
| Category: Cardiovascular | ||||||
| 08/23/2021 | Beckman Coulter, Inc. | UNICEL DXI ACCESS (Device) | Food and Beverage | In-kind items and services | $113.81 | General |
| Category: Devices | ||||||
| 10/28/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $86.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/17/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $77.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $45.42 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,423 | 2,380 | $544,260 | $203,023 |
| 2022 | 9 | 1,116 | 1,989 | $450,440 | $157,024 |
| 2021 | 11 | 899 | 1,598 | $343,405 | $129,273 |
| 2020 | 11 | 1,117 | 1,795 | $387,440 | $146,461 |
Total Patients
4,555
Total Services
7,762
Medicare Billing
$635,780
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 453 | 1,240 | $279,000 | $110,678 | 39.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 375 | 397 | $89,325 | $34,576 | 38.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 305 | 444 | $73,260 | $26,586 | 36.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 180 | 187 | $79,475 | $24,128 | 30.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 87 | 88 | $15,400 | $5,032 | 32.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $7,800 | $2,023 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 462 | 1,239 | $278,775 | $97,336 | 34.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 215 | 221 | $49,725 | $17,927 | 36.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 106 | 110 | $46,750 | $16,160 | 34.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 175 | 194 | $33,950 | $10,641 | 31.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 68 | 129 | $21,285 | $7,146 | 33.6% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 24 | 30 | $5,550 | $2,232 | 40.2% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $5,200 | $2,113 | 40.6% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $4,420 | $1,736 | 39.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 33 | 33 | $4,785 | $1,734 | 36.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 290 | 823 | $184,725 | $70,288 | 38.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 217 | 226 | $39,550 | $13,304 | 33.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 89 | 219 | $36,135 | $12,701 | 35.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 66 | 66 | $28,050 | $11,119 | 39.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 51 | 55 | $12,375 | $4,715 | 38.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 73 | 73 | $10,585 | $4,151 | 39.2% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 30 | 50 | $9,250 | $4,078 | 44.1% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 33 | 33 | $8,580 | $3,530 | 41.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 21 | 22 | $7,480 | $3,168 | 42.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $4,550 | $1,707 | 37.5% |
About Dr. Gilbert Ojong, MD
Dr. Gilbert Ojong, MD is a Internal Medicine healthcare provider based in Longview, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1194137331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilbert Ojong, MD has received a total of $706.35 in payments from pharmaceutical and medical device companies, with $124.41 received in 2024. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($706.35).
As a Medicare-enrolled provider, Ojong has provided services to 4,555 Medicare beneficiaries, totaling 7,762 services with total Medicare billing of $635,780. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Longview, TX
- Active Since 05/22/2014
- Last Updated 05/22/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194137331
Products in Payments
- ELIQUIS (Drug) $360.70
- UNICEL DXI ACCESS (Device) $113.81
- ENTRESTO (Drug) $61.64
- AVYCAZ (Drug) $39.99
- LEQVIO (Drug) $29.32
- DALVANCE (Drug) $24.99
- (8874) inCourage (Device) $15.75
- YUPELRI (Drug) $14.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Longview
Dr. Matei Socoteanu, M.d, M.D
Internal Medicine — Payments: $43,107
Internal Medicine $43,107
Dr. Richard Kirkpatrick, M.d, M.D
Internal Medicine — Payments: $21,956
Internal Medicine $21,956
Dr. Justin Chen, M.d, M.D
Internal Medicine — Payments: $20,021
Internal Medicine $20,021
Dr. Brenda Vozza, Md, MD
Internal Medicine — Payments: $15,247
Internal Medicine $15,247
Dr. Helen Daniel-Glave, Md, MD
Internal Medicine — Payments: $8,759
Internal Medicine $8,759
Dr. Roger Pearce, Md, MD
Internal Medicine — Payments: $8,496
Internal Medicine $8,496